HRT1_Hrt1 Inhibitors
Regarding the detailed description of the chemical class termed as "HRT1_Hrt1 inhibitors," which in the context of this information refers to the indirect inhibition of HEY1, these are chemicals that influence the activity of the protein by modulating the signaling pathways it is a part of, rather than directly binding to or altering the protein itself. HEY1's role as a transcriptional repressor in the Notch signaling pathway, which is implicated in diverse developmental processes and cellular functions, makes it a crucial regulatory node. Therefore, the inhibition of HEY1 typically involves the use of small molecule inhibitors that target upstream components of the Notch pathway, such as gamma-secretase, which is responsible for the release of the Notch intracellular domain, a key step in activating Notch target genes, including HEY1.
The modulation of c-Jun N-terminal kinase (JNK) activity is another strategy, given the involvement of the c-Jun pathway in the regulation of HEY1 expression. Compounds that inhibit JNK can reduce c-Jun-mediated transcription of HEY1. This indirect inhibition strategy is critical for altering the expression levels of HEY1 and its associated downstream effects on cellular processes. In addition, chemicals that affect the NF-kappaB signaling, cyclin-dependent kinases (CDKs), or the PI3K pathway may also exert an indirect inhibitory effect on HEY1 due to the interconnectedness of these pathways with Notch signaling. The breadth of this chemical class is substantial, owing to the complex and multifaceted nature of signaling pathways involved in regulating the activity of HEY1, making these chemicals pivotal in the context of biochemical research focused on transcriptional repression mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT is a gamma-secretase inhibitor that impairs the proteolytic cleavage of Notch receptors, thereby blocking the release and nuclear translocation of the Notch intracellular domain (NICD) which is essential for Notch pathway activation and subsequently downregulates HEY1 transcription. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $198.00 $473.00 | 6 | |
LY411575 serves as a potent and selective gamma-secretase inhibitor. By obstructing the cleavage of Notch, it impedes the signaling cascade, resulting in a decreased expression of Notch target genes including HEY1, affecting processes like differentiation and proliferation. | ||||||
RO-4929097 | 847925-91-1 | sc-364602 sc-364602A | 10 mg 50 mg | $439.00 $1417.00 | 1 | |
This gamma-secretase inhibitor selectively inhibits the Notch signaling pathway by preventing the cleavage of Notch receptors. It reduces the expression of Notch downstream effectors, such as HEY1, thereby affecting cellular differentiation, growth, and apoptosis. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin, a biologically active phytochemical, affects multiple signaling molecules. It can modulate the activity of c-Jun N-terminal kinase (JNK) and, by extension, the c-Jun pathway. This modulation can lead to altered HEY1 activity as c-Jun can regulate its expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that can suppress the activity of c-Jun, a component of the JNK signaling pathway. Inhibition of JNK activity may decrease c-Jun-mediated transcription of target genes, including HEY1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
As an MEK inhibitor, PD98059 can indirectly reduce HEY1 expression by altering the extracellular signal-regulated kinase (ERK) pathway, which collaborates with Notch signaling in certain contexts to regulate gene expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which is involved in cellular responses to stress and cytokines. By inhibiting p38 MAPK, SB203580 can modulate the activity of downstream transcription factors that may influence HEY1 expression. | ||||||
QNZ | 545380-34-5 | sc-200675 | 1 mg | $117.00 | 12 | |
QNZ is an inhibitor of NF-kappaB activation, which may intersect with Notch signaling. By inhibiting NF-kappaB, QNZ could impact the expression of genes regulated by the Notch pathway, including HEY1. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol is a cyclin-dependent kinase inhibitor that may indirectly affect HEY1 expression by altering cell cycle progression and transcription factor activity associated with the Notch pathway. | ||||||
RO-3306 | 872573-93-8 | sc-358700 sc-358700A sc-358700B | 1 mg 5 mg 25 mg | $66.00 $163.00 $326.00 | 37 | |
RO-3306 is a CDK1 inhibitor that arrests cell cycle progression. As CDK1 can influence the Notch signaling by phosphorylating its components, its inhibition can indirectly suppress HEY1 expression. | ||||||